Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce

NCT05216172 is registered in ClinicalTrials.gov with Queen Mary University of London as lead sponsor.

NCT NCT05216172
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05216172 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
AZD1656 in Transplantation With Diabetes tO PromoTe Immune TOleraNce
Lead sponsor
Queen Mary University of London
Phase
Phase 2
Overall status
Completed
Start date
December 13, 2019
Completion date
September 11, 2022
Enrollment
26 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes mellitus, type 2, end stage renal disease, kidney transplant; complications, renal transplant, type 2 diabetes